New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Safety Shot Inc
SHOT
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

62M

Drug Manufacturers - Specialty & Generic

Next Earning date - 21 Nov 2024

62M

Drug Manufacturers - Specialty & Generic

Next Earning date - 21 Nov 2024

1.02USD
Shape-0.04 ( -3.32%)
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-58%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

86%

Quote Panel

Shape
Updated November 9, 2024
1W -4.67 % 1M -20.93 % 3M 56.78 % 1Y -40.35 %

Key Metrics

Shape
  • Market Cap

    61.60M


  • Shares Outstanding

    60.40M


  • Share in Float

    46.90M


  • Dividende

    0


  • Earning Date

    21 Nov 2024


  • Price Target

    1.02


  • Average Volume

    908928


  • Beta

    1.918


  • Range

    0.55-7.5


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.jupiterwellness.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

41.13x

P/S Ratio

8.16x

P/B Ratio

0.4

Debt/Equity

-2494.5%

Net Margin

$-0.9

EPS

How SHOT compares to sector?

P/E Ratio

Relative Strength

Shape

SHOT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$39M

Shape5321%

2024-Revenue

$0.27

Shape267%

2024-EPS

$39M

Shape-363%

2024-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-0.07
vs -0.37

Q3.22

arrow
arrow

N/A

-0.11
vs -0.24

Q4.22

arrow
arrow

N/A

-0.38
vs -0.70

Q1.23

arrow
arrow

N/A

-0.05
vs -0.13

Q2.23

arrow
arrow

N/A

-0.01
vs -0.07

Q3.23

arrow
arrow

N/A

-0.26
vs -0.11

Q4.23

arrow
arrow

N/A

-0.39
vs -0.38

Q1.24

arrow
arrow

N/A

-0.33
vs -0.05

Q2.24

arrow
arrow

N/A

-0.16
vs -0.01

Q3.24

arrow
arrow

+693%

1.54
vs -0.26

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

+404%

3M  vs 595.1K

Q3.22

arrow
arrow

+128%

1.6M  vs 687.9K

Q4.22

arrow
arrow

-41%

905.6K  vs 1.5M

Q1.23

arrow
arrow

+55%

1.1M  vs 721.6K

Q2.23

arrow
arrow

-21%

2.4M  vs 3M

Q3.23

arrow
arrow

-69%

484.2K  vs 1.6M

Q4.23

arrow
arrow

-85%

132.7K  vs 905.6K

Q1.24

arrow
arrow

-85%

170.7K  vs 1.1M

Q2.24

arrow
arrow

-70%

710.2K  vs 2.4M

Q3.24

arrow
arrow

+63%

787.1K  vs 484.2K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-27%

-0.27
vs -0.13

Q4.22

arrow
arrow

-233%

-2.33
vs -0.27

Q1.23

arrow
arrow

-23%

-0.23
vs -2.33

Q2.23

arrow
arrow

-6%

-0.06
vs -0.23

Q3.23

arrow
arrow

-115%

-1.15
vs -0.06

Q4.23

arrow
arrow

-64%

-0.64
vs -1.15

Q1.24

arrow
arrow

-281%

-2.81
vs -0.64

Q2.24

arrow
arrow

-128%

-1.28
vs -2.81

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News